Blueprint Medicines's total assets for Q1 2025 were $1.20B, an increase of 1.34% from the previous quarter. BPMC total liabilities were $853.47M for the fiscal quarter, a -3.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.